{
    "clinical_study": {
        "@rank": "89310", 
        "brief_summary": {
            "textblock": "RATIONALE: Examining biomarkers in fine-needle aspiration specimens from women at risk for\n      breast cancer may improve the ability to detect breast cancer cells early and plan effective\n      treatment.\n\n      PURPOSE: Screening trial to compare specific biomarkers based on fine-needle aspiration\n      specimens from women at increased or normal risk of breast cancer."
        }, 
        "brief_title": "Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer", 
        "completion_date": {
            "#text": "September 2002", 
            "@type": "Actual"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Compare specific biomarkers, including cellular morphology (cytology), proliferation\n           index (Ki-67), p53 expression, and LOH in chromosome 9p at locus DS9157, in fine needle\n           aspirate specimens from women at increased vs normal risk of breast cancer.\n\n        -  Determine whether these specimens are adequate to perform the biomarker assays and\n           whether this technique could be used in the general outpatient setting.\n\n        -  Determine whether biomarker levels in these patients are concordant or discordant with\n           individual clinical risk of breast cancer.\n\n        -  Determine whether 1 or more biomarkers can distinguish high-risk from control patients.\n\n        -  Correlate specific biomarkers and changes in biomarker levels with pathologic diagnosis\n           from the breast biopsy.\n\n      OUTLINE: Patients undergo fine needle aspiration of normal appearing breast tissue prior to\n      the beginning of elective surgery. Specimens are analyzed for the presence of specific\n      biomarkers.\n\n      PROJECTED ACCRUAL: Approximately 156 patients will be accrued for this study within 3 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Increased risk of breast cancer as determined by 1 or more first-degree relatives\n             (mother, sister, or daughter) with a history of breast cancer OR a personal history\n             of atypical hyperplasia, lobular carcinoma in situ, or ductal carcinoma in situ of\n             the breast OR\n\n          -  No increased risk of breast cancer as determined by a lack of the above conditions\n\n          -  Scheduled to undergo elective breast surgery for removal of a mammographic lesion or\n             palpable breast lump\n\n          -  No prior bilateral mastectomy or bilateral breast irradiation\n\n          -  Hormone receptor status:\n\n               -  Not specified\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  30 and over\n\n        Sex:\n\n          -  Female\n\n        Menopausal status:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        Other:\n\n          -  No active invasive malignancy in any site except basal cell or squamous cell skin\n             cancer\n\n          -  No significant medical or psychiatric problems that would preclude study\n\n          -  No evidence of excessive use of narcotics or drug dependency\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  Not specified\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  See Disease Characteristics\n\n        Surgery:\n\n          -  See Disease Characteristics"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 8, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00041353", 
            "org_study_id": "FCCC-02010", 
            "secondary_id": [
                "CDR0000069491", 
                "NCI-G02-2095"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "cytology specimen collection procedure", 
                "intervention_type": "Other"
            }, 
            {
                "intervention_name": "comparison of screening methods", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "study of high risk factors", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "ductal breast carcinoma in situ", 
            "lobular breast carcinoma in situ"
        ], 
        "lastchanged_date": "July 10, 2013", 
        "official_title": "Breast Cancer Biomarkers Based on Fine Needle Aspirates", 
        "overall_official": {
            "affiliation": "Fox Chase Cancer Center", 
            "last_name": "Michael H. Torosian, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2002", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00041353"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Fox Chase Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Fox Chase Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "July 2013", 
        "why_stopped": "Study was not activated at Fox Chase Cancer Center"
    }, 
    "geocoordinates": {}
}